Почетна › Медулобластом › Kalifornija
Kliničke studije za Медулобластом u državi Kalifornija
6 studija za Медулобластом traži učesnike na lokacijama u državi Kalifornija.
Gradovi u državi Kalifornija
Zvanični tekst studije (na engleskom)
GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
- Lucile Packard Children's Hospital Stanford, Palo Alto
Тражи се учесникФаза 1
Узраст од 1 до 30 · Оба пола · Ажурирано 9. 10. 2026. · NCT07087002Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease
- University of California, San Francisco, San Francisco
Тражи се учесникФаза 1/2
Узраст од 1 до 25 · Оба пола · Ажурирано 28. 9. 2026. · NCT07346157Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
- Lucille Packard Children's Hospital Stanford, Palo Alto
Тражи се учесникФаза 2
59 Months · Оба пола · Ажурирано 15. 9. 2026. · NCT05535166A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
- Loma Linda University Medical Center, Loma Linda
- Miller Children's and Women's Hospital Long Beach, Long Beach
- Children's Hospital Los Angeles, Los Angeles
- и још 6
Тражи се учесникФаза 3
Узраст од 4 до 21 · Оба пола · Ажурирано 25. 8. 2026. · NCT05382338DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
- UCSF Benioff Children's Hospital Oakland, Oakland
- UC Davis Comprehensive Cancer Center, Sacramento
- Rady Children's Hospital, San Diego
- и још 1
Тражи се учесникФаза 2
До 21 година · Оба пола · Ажурирано 12. 8. 2026. · NCT04696029Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma
- Children's Hospital of Los Angeles, Los Angeles
- Rady Children's Hospital, San Diego
- University of California, San Francisco, San Francisco
Тражи се учесник
12 Months – 39 Years · Оба пола · Ажурирано 11. 8. 2026. · NCT05057702Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.